Expanded Access for CC-4047

Celgene

Status

Conditions: Multiple Myeloma

Treatments: Drug: CC-4047

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03723096

CC-4047

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-4047.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria